Charles M. LeVea MD, PhD
Charles M. LeVea
MD, PhD
Clinical Assistant Professor
Department of Pathology and Anatomical Sciences
Jacobs School of Medicine & Biomedical Sciences
Specialty/Research Focus
Anatomic Pathology; Clinical Pathology
Education and Training:
- MD, Medicine, SUNY at Stony Brook (1996)
- PhD, Pathology, University of Pennsylvania (1992)
- MS, Biochemistry, University or Rochester (1987)
Employment:
- Clinical Assistant Professor, Roswell Park Cancer Institute (2004-present)
Journal Articles:
- Wintrob ZA, Oppong EK, Foster M, Martorana M, Tse YC, Zhong L, Welt JM, Boateng HR, Drumea IM, Irlam J, Levea CM, Faitar SL, Ceacareanu AC. (2014) Sexual dimorphism, weight gain and glucose intolerance in a B- and T-cell deficient mouse model. Cytokine (Jun), 67(2): 102-106.
- Dy GK, Nesline MK, Papanicolau-Sengos A, DePietro P, LeVea CM, Early A, Chen H, Grand'Maison A, Boland P, Ernstoff MS, Edge S, Akers S, Opyrchal M, Chatta G, Odunsi K, Pabla S, Conroy JM, Glenn ST, DeFedericis HT, Burgher B, Andreas J, Giamo V, Qin M, Wang Y, Kanehira K, Lenzo FL, Frederick P, Lele S, Galluzzi L, Kuvshinoff B, Morrison C. (2019) Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing. BMC Med Inform Decis Mak (Jan), 19(1): 14-14.
- Samuel S, Mukherjee S, Ammannagari N, Pokuri VK, Kuvshinoff B, Groman A, LeVea CM, Iyer R. (2018) Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study. PLoS One (Jun), 13(6): 0198809-0198809.
- Singla S, LeVea CM, Pokuri VK, Attwood KM, Wach MM, Tomaszewski GM, Kuvshinoff B, Iyer R. (2016) Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience. J Gastrointest Oncol (Jun), 7(3): 441-448.
- Nurkin SJ, Nava HR, Yendamuri S, LeVea CM, Nwogu CE, Groman A, Wilding G, Bain AJ, Hochwald SN, Khushalani NI. (2014) Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer. Surg Endosc (Apr), 28(4): 1090-1095.
- Nurkin SJ, Nava HR, Yendamuri S, LeVea CM, Nwogu CE, Groman A, Wilding G, Bain AJ, Hochwald SN, Khushalani NI. (2014) Outcomes of endoscopic resection for high-grade dysplasia and esophageal cancer. Surg Endosc (Apr), 28(4): 1090-1095.
- Dewanwala A, Kotowski A, Levea CM, Ma WW, Ma W. (2011) Secondary Tumors of the Pancreas: Case Report and a Single-Center Experience. J Gastrointest Cancer (Sep).
- Pande AU, Iyer RV, Rani A, Maddipatla S, Yang GY, Nwogu CE, Black JD, Levea CM, Javle MM. (2008) Epidermal growth factor receptor-directed therapy in esophageal cancer. Oncology (May), 73(5-6): 281-289.
- Javle MM, Tan D, Yu J, LeVea CM, Li F, Kuvshinoff BW, Gibbs JF. (2004) Nuclear survivin expression predicts poor outcome in cholangiocarcinoma. Hepatogastroenterology (Nov), 51(60): 1653-1657.